Aerovate Therapeutics Future Growth
Future criteria checks 0/6
Aerovate Therapeutics is forecast to grow earnings and revenue by 4.5% and 73.9% per annum respectively while EPS is expected to grow by 14.4% per annum.
Key information
4.5%
Earnings growth rate
14.4%
EPS growth rate
| Biotechs earnings growth | 24.0% |
| Revenue growth rate | 73.9% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 04 Apr 2024 |
Recent future growth updates
Recent updates
Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 09
We're Not Very Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Rate
Oct 17Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Jul 04Aerovate Therapeutics (NASDAQ:AVTE) Is In A Good Position To Deliver On Growth Plans
Feb 28A Look At The Fair Value Of Aerovate Therapeutics, Inc. (NASDAQ:AVTE)
Jan 06Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Oct 14Here's Why We're Not Too Worried About Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation
Jul 01We Think Aerovate Therapeutics (NASDAQ:AVTE) Can Afford To Drive Business Growth
Jan 22Companies Like Aerovate Therapeutics (NASDAQ:AVTE) Are In A Position To Invest In Growth
Sep 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4 | -103 | -70 | -90 | 6 |
| 12/31/2025 | N/A | -100 | -86 | -69 | 7 |
| 12/31/2024 | N/A | -89 | -81 | -66 | 7 |
| 12/31/2023 | N/A | -76 | -57 | -57 | N/A |
| 9/30/2023 | N/A | -70 | -57 | -57 | N/A |
| 6/30/2023 | N/A | -64 | -51 | -51 | N/A |
| 3/31/2023 | N/A | -57 | -45 | -45 | N/A |
| 12/31/2022 | N/A | -52 | -39 | -39 | N/A |
| 9/30/2022 | N/A | -45 | -38 | -37 | N/A |
| 6/30/2022 | N/A | -37 | -34 | -34 | N/A |
| 3/31/2022 | N/A | -31 | -29 | -29 | N/A |
| 12/31/2021 | N/A | -23 | -28 | -27 | N/A |
| 9/30/2021 | N/A | -18 | -17 | -17 | N/A |
| 6/30/2021 | N/A | -15 | -13 | -13 | N/A |
| 3/31/2021 | N/A | -11 | -10 | -10 | N/A |
| 12/31/2020 | N/A | -10 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVTE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AVTE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AVTE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AVTE is forecast to have no revenue next year.
High Growth Revenue: AVTE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AVTE's Return on Equity is forecast to be high in 3 years time